FDA okays ViiV’s Apretude as first injectable for HIV PrEP
Digital pill tracks HIV PrEP adherence with 98% accuracy
Humira tops list of drugs with unwarranted US price hikes
Gilead will challenge US government patent on PrEP drug Truvada
Gilead files Truvada follow-up Descovy for PrEP
National AIDS Trust continues legal battle over Truvada.
Charity raises funds for legal fight over HIV drug
But there are funding problems in UK, Australia and Canada.
EU approves Gilead’s Truvada for HIV prevention
CHMP backs HIV pre-exposure prophylaxis use.
Gilead’s Truvada backed in EU for HIV prevention